<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2">The introduction of conjugate vaccines against 
 <italic>Haemophilus influenzae</italic> type b and 
 <italic>Streptococcus pneumoniae</italic> in many countries has contributed to reductions in pneumonia deaths over the last two decades
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>,
  <xref ref-type="bibr" rid="CR2">2</xref>
 </sup>. The introduction of pneumococcal conjugate vaccine in The Gambia was associated with a 61% reduction in severe hypoxic pneumonia
 <sup>
  <xref ref-type="bibr" rid="CR3">3</xref>
 </sup>. However, the incidence of all-cause acute lower respiratory infection (ALRI) remains high
 <sup>
  <xref ref-type="bibr" rid="CR33">3</xref>
 </sup> with an estimated 921,000 deaths due to ALRI in children &lt;5 years of age in 2015, 490 000 of which occurred in sub-Saharan Africa
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup>.
</p>
